Surgery
Radiation Therapy
Drug Therapy
Timing of Treatment
200

The surgical removal of a small segment of the lung.

Segmentectomy.

200

This modality involves a lower dose of x-ray beams to target and kill cancer cells. Typically, the patient undergoes 20-30 sessions for 3-6 weeks.

External beam radiation therapy (EBRT).

200

This modality is used before surgery, to decrease tumour size and facilitate removal.

Neoadjuvant chemotherapy.

200

This category of treatment is used primarily during the earlier stages of cancer, in order to target a primary tumour.

Local.

200

The surgical removal of an entire lobe of the lung.

Lobectomy.

200

This modality involves a higher dose of x-ray beams to target and kill cancer cells. Typically, the patient undergoes 1-5 sessions for 1-2 weeks.

Stereotactic body radiation therapy (SBRT).

200

This modality is used after surgery, to decrease recurrence risk.

Adjuvant chemotherapy.

200

This category of treatment is used primarily during the later stages of cancer, in order to target secondary tumours, or cancer that has otherwise metastasized.

Systemic.

300

The surgical removal of an entire lung.

Pneumonectomy.

300

This modality is used in conjunction with radiation therapy, to increase its effectiveness.

Chemoradiation.

300

Classify surgery, radiation therapy, and drug therapy as local or systemic therapies (3/3 correct).

-Surgery = local

-Radiation therapy = local

-Drug therapy = systemic

400

The type of surgery which is chosen is dependent on (list 2/3 factors)?

-Size and location of the cancer

-Lung function

-Overall health

400

This modality inhibits PD-L1 proteins, which inhibit immune cells from killing cancer cells.

Immunotherapy.

400

True or false: In the context of lung cancer, generally, only one treatment modality is administered at a time.

False. Most often, patients will be treated with multiple modalities at a time.

500

Other structures which are commonly removed during surgery for lung cancer and investigated for the spread of cancer cells.

Lymph nodes.

500

This modality targets specific molecular targets which are the result of protein changes due to gene mutations.

Targeted therapy.

500

True or false: Palliative care is only used when a patient's lung cancer has advanced to stage 4.

False. Palliative care encompasses a wide range of supports which are intended to improve a patient's quality of life for the duration of their treatment. As such, it may be used at any stage concurrently with curative care.